Back to Feed
Series D+

Quanta Dialysis Technologies raises £47.4m in Series E funding led by Novo Holdings, Glenview Capital and b2venture to expand commercial operations.

Quanta Dialysis Technologies

Novo Holdings, Glenview Capital and b2venture led the Series E round, which will fund commercial expansion in the US.

£47.4MSeries D+

Quanta Dialysis Technologies develops the compact Quanta Dialysis System to make kidney care accessible across multiple clinical and home settings. The firm received the MacRobert Award for engineering innovation in 2022.

Quanta Dialysis Technologies has secured £47.4m in a Series E funding round led by Novo Holdings, Glenview Capital, and b2venture, alongside participation from existing backers. The fresh capital will be deployed to scale commercial operations in the United States and fund ongoing technical innovation.

The financing follows recent regulatory milestones for the company, including FDA clearance for home hemodialysis applications. The firm aims to build on its position in the acute care segment and expand its reach into chronic and sub-acute treatment environments.


From the founder

"Our commitment to delivering innovative solutions for acute care has never been stronger. This financing round provides the resources to solidify Quanta as the best-in-class solution across the care continuum, to significantly expand our commercial operations, while continuing to introduce enhancements that will strengthen our long-term competitive position."
AG

Alejandro Galindo

Chief Executive Officer at Quanta Dialysis Technologies


Investor perspective

"Quanta’s compelling product-market fit within the $1.5 billion acute care segment is demonstrated by its ability to win contracts over well-established legacy CRRT and IHD competitors. The recent FDA clearance for the home setting is transformational for patients and significantly expands Quanta’s addressable market into the chronic and sub-acute segments."
RG

Robert Ghenchev

Managing Partner of Growth Investments, Novo Holdings


Use of funds

  1. 01Expand into international markets
  2. 02Fund research and development

Investors

Novo Holdings

Robert Ghenchev

Novo Holdings

GC

Lloyd Mandell

Glenview Capital

b

b2venture


Categories

HardwareMedTech

About the company

Quanta Dialysis Technologies

Quanta Dialysis Technologies

Quanta Dialysis Technologies provides compact dialysis systems for clinical and home use.

Beverly, MA, USA Website
£223MRaised